Program
 

Tuesday, November 6, 2007
12:00pm-5:00pm	Registration
	AMP Council Meeting, (Part I)
Wednesday, November 7, 2007
7:30am-3:30pm	Pathology Outreach Course, Premier Sponsor: Nanosphere, Inc.
8:00am-5:00pm	Registration
9:00am-5:00pm	Corporate Workshops
5:00pm-6:15pm	MGP Fellowship Program Directors Meeting
5:45pm-7:45pm	Abbott Molecular Evening Reception
6:30pm-8:00pm	AMP Committee Meetings
8:00pm-9:30pm	AMP Strategic Planning Committee Meeting
Thursday, November 8, 2007
7:45am	Opening Remarks, Karen E. Weck, MD, University of North Carolina at Chapel Hill, Chapel Hill, NC
8:00am-9:15am	AMP AWARD FOR EXCELLENCE IN MOLECULAR DIAGNOSTICS LECTURE Janet D. Rowley, MD, University of Chicago, Chicago, IL
9:15am-10:30am	Break/Visit Exhibits
10:30am-12:00noon	PLENARY SESSION I - Genetics
		Familial Cancer Moderators: Paul G. Rothberg, PhD, University of Rochester Medical Center, Rochester, NY and Mary C. Lowery Nordberg, PhD, Louisiana State University Health Sciences Center, Shreveport, LA
		Familial Kidney Cancer Jorge R. Toro, MD, National Cancer Institute, Rockville, MD
		Familial Pancreatic Cancer Alison Klein, PhD, Johns Hopkins Medical Institutions, Baltimore, MD
12:00noon-1:15pm	Infectious Diseases Subdivision Business Luncheon*
	Solid Tumors Subdivision Business Luncheon*
	General Luncheon
1:15pm-2:30pm	HEMATOPATHOLOGY WORKSHOP I
		Molecular Stratification and Targeting of Aggressive B-cell Lymphomas Moderator: Dan Jones, MD, PhD, UT - MD Anderson Cancer Center, Houston, TX
		Genomic Profiling for Choosing Drug Targets in Large Cell and Mantle Cell Lymphoma: Focus on p53 Timothy C. Greiner, MD, University of Nebraska Medical Center, Omaha, NE
		Identifying New Targets in Lymphoma: Focus on BCL6 Ari Melnick, MD, Albert Einstein College of Medicine, Bronx, NY
1:15pm-2:30pm	GENETICS WORKSHOP I Moderator: Mary C. Lowery Nordberg, PhD, LSU Health Sciences Center, Shreveport, LA
		Puzzlers by Prior Thomas W. Prior, PhD, Ohio State University, Columbus, OH
2:30pm-4:30pm	Visit Exhibits & Posters (Odd-numbered posters manned)
4:30pm-5:45pm	SOLID TUMORS WORKSHOP I Moderator: Deborah Dillon, MD, Brigham and Women's Hospital, Boston, MA CpG Methylation Testing: Clinical Applications in the Evaluation of Neoplastic Diseases
		Goals and Future Projects of the AMP Methylation Working Group Antonia Sepulveda, MD, PhD, Hospital of the University of Pennsylvania, Philadelphia, PA
		Methods of  CpG Methylation Testing Shuji Ogino, MD, PhD, Brigham & Women's Hospital, Boston, MA
		New and Alternative Methods for CpG Methylation Testing Victor V. Levenson, MD, PhD, Northwestern University Cancer Center, Chicago, IL
		CpG Methylation Testing in Colon Cancer-MSI and CIMP Tumor Phenotypes Wade S. Samowitz, MD, ARUP Laboratories, Salt Lake City, UT
		CpG Methylation Testing in Cytological Specimens Bin Yang, MD, PhD, Cleveland Clinic, Cleveland, OH
		CpG Methylation Testing for Cancer Therapy Monitoring Dan Jones, MD, PhD, UT - MD Anderson Cancer Center, Houston, TX
4:30pm-5:45pm	INFECTIOUS DISEASES WORKSHOP I
		Bordetella Pertussis Assays and Standardization Moderator: Franklin Cockerill III, MD, Mayo Clinic, Rochester, MN
		Results of a Multicenter Study Gregory J. Tsongalis, PhD, Dartmouth Medical School, Lebanon, NH
		The Public Health Perspective Maria Lucia C. Tondella, PhD, Centers for Disease Control and Prevention, Atlanta, GA
4:30pm-5:45pm	TECHNICAL TOPICS WORKSHOP
		Techniques for Detection of Gene Copy Number - Beyond Southern Blot Moderators: Malinda Butz, BS, CLSp (MB), Mayo Clinic, Rochester, MN Karen Bijwaard, MS, CLSp (MB), FDA, Rockville, MD
		Large Gene Rearrangement Detection by Commercially Available MLPA Assays Rong Mao, MD, ARUP Laboratories, Salt Lake City, UT
		Multiplex Ligation-Dependent Probe Amplification (MLPA): Laboratory Developed Tests Patrick Lundquist, BS, CLSp (MB), CLSp (CG), Mayo Clinic, Rochester, MN
		Quantitative Multiplex PCR Analysis for Large Gene Rearrangements Benjamin Roa, PhD, Myriad Genetics Laboratories, Salt Lake City, UT
		Quantitative Microsphere Hybridization Joan Knoll, PhD, University of Western Ontario, London, Ontario, CANADA
5:45 pm-7:00pm	Welcome Reception Supported by Roche Diagnostics Corporation
Friday, November 9, 2007
7:00am-7:50am	Early Bird Sessions
		Validation and Maintenance of ASRs and Lab Developed Assays Wayne W. Grody, MD, PhD, UCLA School of Medicine, Los Angeles, CA Margaret L. Gulley, MD, University of North Carolina at Chapel Hill, Chapel Hill, NC
		Mutation Nomenclature  >>Download Nomenclature Quiz Shuji Ogino, MD, PhD, Brigham & Women's Hospital, Boston, MA
8:00am-9:30 am	PLENARY SESSION II: Technical Topics
		Highly Multiplexed Molecular Assays Moderators: Karen Bijwaard, MS, CLSp (MB), FDA, Rockville, MD Malinda Butz, BS, CLSp (MB), Mayo Clinic, Rochester, MN
		Highly Multiplexed Infectious Disease Assays David R. Hillyard, MD, ARUP Laboratories, Salt Lake City, UT
		Applications and Issues with Multiplex Analysis for Genetic and Hematology/Oncology Assays Gregory J. Tsongalis, PhD, Dartmouth Medical School, Lebanon, NH
9:30am-10:00am	Break
10:00am-11:30am	PLENARY SESSION III: Infectious Diseases
		Molecular Testing for Infection Prevention and Therapeutic Guidance Moderator: Alexandra Valsamakis, MD, PhD, The Johns Hopkins Medical Institutions, Baltimore, MD
		Molecular Testing for Antibiotic Resistance Lance R. Peterson, MD, Evanston Northwestern Healthcare, Evanston, IL
		The Role of the Virologic Assay in the Management and Treatment of Patients with Chronic Hepatitis C Virus Mitchell L. Shiffman, MD, VCU Medical Center, Richmond, VA
11:30am-1:00pm	Genetics Subdivision Business Luncheon*
	Hematopathology Subdivision Business Luncheon
	General Luncheon
1:00pm - 3:00pm	Visit Exhibits and Posters (Even-numbered posters manned)
3:00pm-4:15pm	HEMATOPATHOLOGY WORKSHOP II
		Algorithmic Approaches to the Diagnosis of the Myeloproliferative Disorders Moderators: Dan Jones, MD, PhD, UT- MD Anderson Cancer Center, Houston, TX Lynne V. Abruzzo, MD, PhD, UT- MD Anderson Cancer Center, Houston, TX
		Molecular Algorithms for Diagnosis of Chronic Myeloproliferative Disorders John Anastasi, MD, University of Chicago, Chicago, IL
		Platform Presentations of Selected Hematopathology Abstracts H35 Quantifying Acquired JAK2 V617F Mutation in Myeloproliferative Disorders by Real-time Polymerase Chain Reaction Scott Reading, PhD, ARUP Laboratories, Salt Lake City, UT H30 JAK2 Mutation Quantification in Myeloproliferative Disorders (MPD); Correlation with  Diagnosis and Clinical Parameters Amanda Wilson, MD, Evanston Northwestern Healthcare, Evanston, IL H27 Targeted Detection of BCR-ABL Kinase Domain Mutations Using FlexMap Microspheres and Luminex Bead Array Technology Lori A. Frederick, BS, Mayo Clinic, Rochester, MN H43 Ultrafast, High-Throughput Sequencing-by-Hybridization Assay for Insertion Mutations in the Nucleophosmin 1 Gene German Pihan, MD, Beth Israel Deaconess Medical Center, Boston, MA
3:00pm-4:15pm	INFECTIOUS DISEASES WORKSHOP II
		Moderator: Alexandra Valsamakis, MD, PhD, The Johns Hopkins Medical Institutions, Baltimore, MD
		Platform Presentations of Selected Infectious Diseases Abstracts
		ID57 Spread of KPC Carbapenemase-producing K. pneumoniae to North Florida Kenneth H. Rand, MD, University of Florida, Gainesville, FL ID36 Clinical Aspects of HPV Genotyping in Adolescents Brandi K. Painter, MD, Louisiana State University Health Sciences Center, Shreveport, LA ID59 Using Real-time PCR to Identify Community-Associated MRSA by Detecting Panton-Valentine Leukocidin Suzanne M. Paule, BS, Evanston Northwestern Healthcare, Evanston, IL ID23 High Prevalence of Multiple Respiratory Virus Infections Associated with the WU Polyomavirus Max Arens, PhD, Washington University, St. Louis, MO ID17 Use of Web-Based EDCNet and OptiQual External Positive Controls to Monitor Quality Performance of User-Defined & FDA-Approved Assays for Viral Load Testing Donna M. Wolk, PhD D(ABMM), University of Arizona, Tucson, AZ
4:30pm-6:00pm	AMP Poster Reception Supported by Gen-Probe, Inc
6:00pm-7:00pm	AMP Methylation Working Group Meeting
7:00pm-10:00pm	The Journal of Molecular Diagnostics (JMD) Editorial Board Meeting Supported by Eragen Biosciences
7:00pm-11:00pm	Dinner for Canadian AMP Members
Saturday, November 10, 2007
7:00am-7:50am	Early Bird Sessions
		Quantitative Testing for EBV: Diagnostic Issues and Assay Standardization Moderator: Alexandra Valsamakis, MD, PhD, The Johns Hopkins Medical Institutions, Baltimore, MD Margaret L. Gulley, MD, University of North Carolina-Chapel Hill, Chapel Hill, NC Randall Hayden, MD, St. Jude Children's Research Hospital, Memphis, TN Jutta K. Preiksaitis, MD, ProvLab and University of Alberta, Edmonton, AB, Canada
		Overview of Billable Tests in Solid Tumors Moderator: William P. Bennett, MD, City of Hope National Medical Center, Duarte, CA
		FISH Analysis of HER2 in Breast Cancer and UroVysionTM for Bladder Cancer Kevin C. Halling, MD, PhD, Mayo Foundation, Rochester, MN
		MSI Testing for Colon Cancer Jennifer L. Hunt, MD, Cleveland Clinic Foundation, Cleveland, OH
		1p-19q Translocation in Oligodendrogliomas Kathleen M. Murphy, PhD, Johns Hopkins University School of Medicine, Baltimore, MD
		Translocations in Sarcomas Raymond R. Tubbs, DO, Cleveland Clinic Foundation, Cleveland, OH
		c-Kit Alterations in GISTs Christopher L. Corless, MD, PhD, Oregon Health Sciences University, Portland, OR
8:00am-9:30am	PLENARY SESSION IV: Hematopathology
		New Insights into Leukemia and Lymphoma Moderator: Lynne V. Abruzzo, MD, PhD, UT-MD Anderson Cancer Center, Houston, TX
		DNA Double Strand Breaks, Translocations, and Lymphoma Frederick W. Alt, PhD, Harvard University, Boston, MA
		Cancer Stem Cells: Diagnostic and Therapeutic Challenges Catriona Jamieson, MD, PhD, UCSD Medical Center, La Jolla, CA
9:30am-10:00am	Break
10:00am-11:30am	PLENARY SESSION V: Solid Tumors
		Novel Molecular Biomarkers for Solid Tumors Moderator: Deborah Dillon, MD, Brigham and Women's Hospital, Boston, MA
		Genetic Variation at 8q24 and Cancer Risk Christopher Haiman, PhD, University of Southern California, Los Angeles, CA
		TMPRSS2-ERG Fusion Prostate Cancer: A Distinct Subclass with Clinical Implications Mark Rubin, MD, Weill Cornell Medical College, New York, NY
11:30am-12:30pm	General Luncheon
	Trainee Luncheon
		Career Paths for Molecular Pathologists in Both Academia and Other Settings Daniel H. Farkas, PhD, HCLD, Center for Molecular Medicine, Grand Rapids, MI Jeffrey A. Kant, MD, PhD, University of Pittsburgh Medical Center, Pittsburgh, PA Debra G. B. Leonard, MD, PhD, New York Presbyterian Hospital, New York, NY Janina A. Longtine, MD, Brigham & Women's Hospital, Boston, MA Ted E. Schutzbank, PhD, CompuNET CLinical Laboratories, Moraine, OH
12:45pm-2:00pm	SOLID TUMORS WORKSHOP II
		Gene Expression Testing in Breast Cancer - Panel Discussion Moderator: William P. Bennett, MD, City of Hope National Medical Center, Duarte, CA Philip Bernard, MD, University of Utah, Salt Lake City, UT Mark G. Erlander, PhD, AviaraDx, Inc, Carlsbad, CA Steven Shak, MD, Genomic Health, Inc., Redwood City, CA W. Fraser Symmans, MD, UT-MD Anderson Cancer Center, Houston, TX
12:45pm-2:00pm	GENETICS WORKSHOP II
		Pharmacogenetics of Warfarin Therapy Moderator: Paul G. Rothberg, PhD, University of Rochester Medical Center, Rochester, NY
		Pharmacogenetics and www.warfarindosing.com Brian F. Gage, MD, Washington University School of Medicine, St. Louis, MO
		Panel Discussion: Implementation of a Program to Aid in Warfarin Dosing Rana Domiati-Saad, PhD, Baylor University Medical Center, Dallas, TX Brian F. Gage, MD, Washington University School of Medicine, St. Louis, MO Mary Lowery Nordberg, PhD, LSU Health Sciences Center, Shreveport, LA Gregory J. Tsongalis, PhD, Dartmouth Medical School, Lebanon, NH Karen E. Weck, MD, University of North Carolina at Chapel Hill, Chapel Hill, NC
2:15pm- 3:45pm	SPECIAL TOPICS WORKSHOP
		Molecular Meat and Potatoes: Reimbursement and Regulatory Issues Moderator: Karen E. Weck, MD, University of North Carolina at Chapel Hill, Chapel Hill, NC
		Coding Conundrums: The AMPire Strikes Back Jeffrey A. Kant, MD, PhD, University of Pittsburgh Medical Center, Pittsburgh, PA
		Legislative & Regulatory Issues Update Andrea Ferreira-Gonzalez, PhD, Virginia Commonwealth University, Richmond, VA Debra G. B. Leonard, MD, PhD, New York Presbyterian Hospital, New York, NY
4:00pm-5:15pm	Business Meeting/Awards Presentation/Closing Remarks
5:15pm-6:30pm	Awards Reception Supported by Third Wave Technologies
6:30pm- 9:30pm	AMP Council Meeting (Part II)
*Seating is limited and therefore by pre-registration ticket only.